The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glycomics & Glycobiology-Global Market Insights and Sales Trends 2025
Synopsis
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The global Glycomics & Glycobiology market size is expected to reach US$ 2470.4 million by 2029, growing at a CAGR of 11.5% from 2023 to 2029. The market is mainly driven by the significant applications of Glycomics & Glycobiology in various end use industries. The expanding demands from the Drug Discovery & Development, Diagnostics and Others,, are propelling Glycomics & Glycobiology market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymes segment is estimated at % CAGR for the next seven-year period.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycomics & Glycobiology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycomics & Glycobiology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycomics & Glycobiology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycomics & Glycobiology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycomics & Glycobiology covered in this report include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega and Waters Corporation, etc.
The global Glycomics & Glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Global Glycomics & Glycobiology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycomics & Glycobiology market, Segment by Type:
Instruments
Enzymes
Reagents
Kits
Global Glycomics & Glycobiology market, by Application
Drug Discovery & Development
Diagnostics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycomics & Glycobiology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
The global Glycomics & Glycobiology market size is expected to reach US$ 2470.4 million by 2029, growing at a CAGR of 11.5% from 2023 to 2029. The market is mainly driven by the significant applications of Glycomics & Glycobiology in various end use industries. The expanding demands from the Drug Discovery & Development, Diagnostics and Others,, are propelling Glycomics & Glycobiology market. Instruments, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Enzymes segment is estimated at % CAGR for the next seven-year period.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glycomics & Glycobiology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glycomics & Glycobiology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glycomics & Glycobiology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glycomics & Glycobiology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glycomics & Glycobiology covered in this report include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega and Waters Corporation, etc.
The global Glycomics & Glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ThermoFisher Scientific
Danaher
Shimadzu Corporation
ProZyme
Takara Bio, Inc.
Agilent Technologies
Bruker
Promega
Waters Corporation
R&D Systems
New England Biolabs
Merck KGaA
Global Glycomics & Glycobiology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glycomics & Glycobiology market, Segment by Type:
Instruments
Enzymes
Reagents
Kits
Global Glycomics & Glycobiology market, by Application
Drug Discovery & Development
Diagnostics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glycomics & Glycobiology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Glycomics & Glycobiology
1.1 Glycomics & Glycobiology Market Overview
1.1.1 Glycomics & Glycobiology Product Scope
1.1.2 Glycomics & Glycobiology Market Status and Outlook
1.2 Global Glycomics & Glycobiology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Glycomics & Glycobiology Market Size by Region (2018-2029)
1.4 Global Glycomics & Glycobiology Historic Market Size by Region (2018-2023)
1.5 Global Glycomics & Glycobiology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Glycomics & Glycobiology Market Size (2018-2029)
1.6.1 North America Glycomics & Glycobiology Market Size (2018-2029)
1.6.2 Europe Glycomics & Glycobiology Market Size (2018-2029)
1.6.3 Asia-Pacific Glycomics & Glycobiology Market Size (2018-2029)
1.6.4 Latin America Glycomics & Glycobiology Market Size (2018-2029)
1.6.5 Middle East & Africa Glycomics & Glycobiology Market Size (2018-2029)
2 Glycomics & Glycobiology Market by Type
2.1 Introduction
2.1.1 Instruments
2.1.2 Enzymes
2.1.3 Reagents
2.1.4 Kits
2.2 Global Glycomics & Glycobiology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Glycomics & Glycobiology Historic Market Size by Type (2018-2023)
2.2.2 Global Glycomics & Glycobiology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Glycomics & Glycobiology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Glycomics & Glycobiology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Glycomics & Glycobiology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Glycomics & Glycobiology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Glycomics & Glycobiology Revenue Breakdown by Type (2018-2029)
3 Glycomics & Glycobiology Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery & Development
3.1.2 Diagnostics
3.1.3 Others
3.2 Global Glycomics & Glycobiology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Glycomics & Glycobiology Historic Market Size by Application (2018-2023)
3.2.2 Global Glycomics & Glycobiology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Glycomics & Glycobiology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Glycomics & Glycobiology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Glycomics & Glycobiology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Glycomics & Glycobiology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Glycomics & Glycobiology Revenue Breakdown by Application (2018-2029)
4 Glycomics & Glycobiology Competition Analysis by Players
4.1 Global Glycomics & Glycobiology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glycomics & Glycobiology as of 2022)
4.3 Date of Key Players Enter into Glycomics & Glycobiology Market
4.4 Global Top Players Glycomics & Glycobiology Headquarters and Area Served
4.5 Key Players Glycomics & Glycobiology Product Solution and Service
4.6 Competitive Status
4.6.1 Glycomics & Glycobiology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ThermoFisher Scientific
5.1.1 ThermoFisher Scientific Profile
5.1.2 ThermoFisher Scientific Main Business
5.1.3 ThermoFisher Scientific Glycomics & Glycobiology Products, Services and Solutions
5.1.4 ThermoFisher Scientific Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.1.5 ThermoFisher Scientific Recent Developments
5.2 Danaher
5.2.1 Danaher Profile
5.2.2 Danaher Main Business
5.2.3 Danaher Glycomics & Glycobiology Products, Services and Solutions
5.2.4 Danaher Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.2.5 Danaher Recent Developments
5.3 Shimadzu Corporation
5.3.1 Shimadzu Corporation Profile
5.3.2 Shimadzu Corporation Main Business
5.3.3 Shimadzu Corporation Glycomics & Glycobiology Products, Services and Solutions
5.3.4 Shimadzu Corporation Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.3.5 ProZyme Recent Developments
5.4 ProZyme
5.4.1 ProZyme Profile
5.4.2 ProZyme Main Business
5.4.3 ProZyme Glycomics & Glycobiology Products, Services and Solutions
5.4.4 ProZyme Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.4.5 ProZyme Recent Developments
5.5 Takara Bio, Inc.
5.5.1 Takara Bio, Inc. Profile
5.5.2 Takara Bio, Inc. Main Business
5.5.3 Takara Bio, Inc. Glycomics & Glycobiology Products, Services and Solutions
5.5.4 Takara Bio, Inc. Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.5.5 Takara Bio, Inc. Recent Developments
5.6 Agilent Technologies
5.6.1 Agilent Technologies Profile
5.6.2 Agilent Technologies Main Business
5.6.3 Agilent Technologies Glycomics & Glycobiology Products, Services and Solutions
5.6.4 Agilent Technologies Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.6.5 Agilent Technologies Recent Developments
5.7 Bruker
5.7.1 Bruker Profile
5.7.2 Bruker Main Business
5.7.3 Bruker Glycomics & Glycobiology Products, Services and Solutions
5.7.4 Bruker Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.7.5 Bruker Recent Developments
5.8 Promega
5.8.1 Promega Profile
5.8.2 Promega Main Business
5.8.3 Promega Glycomics & Glycobiology Products, Services and Solutions
5.8.4 Promega Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.8.5 Promega Recent Developments
5.9 Waters Corporation
5.9.1 Waters Corporation Profile
5.9.2 Waters Corporation Main Business
5.9.3 Waters Corporation Glycomics & Glycobiology Products, Services and Solutions
5.9.4 Waters Corporation Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.9.5 Waters Corporation Recent Developments
5.10 R&D Systems
5.10.1 R&D Systems Profile
5.10.2 R&D Systems Main Business
5.10.3 R&D Systems Glycomics & Glycobiology Products, Services and Solutions
5.10.4 R&D Systems Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.10.5 R&D Systems Recent Developments
5.11 New England Biolabs
5.11.1 New England Biolabs Profile
5.11.2 New England Biolabs Main Business
5.11.3 New England Biolabs Glycomics & Glycobiology Products, Services and Solutions
5.11.4 New England Biolabs Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.11.5 New England Biolabs Recent Developments
5.12 Merck KGaA
5.12.1 Merck KGaA Profile
5.12.2 Merck KGaA Main Business
5.12.3 Merck KGaA Glycomics & Glycobiology Products, Services and Solutions
5.12.4 Merck KGaA Glycomics & Glycobiology Revenue (US$ Million) & (2018-2023)
5.12.5 Merck KGaA Recent Developments
6 North America
6.1 North America Glycomics & Glycobiology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Glycomics & Glycobiology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Glycomics & Glycobiology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Glycomics & Glycobiology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Glycomics & Glycobiology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Glycomics & Glycobiology Market Dynamics
11.1 Glycomics & Glycobiology Industry Trends
11.2 Glycomics & Glycobiology Market Drivers
11.3 Glycomics & Glycobiology Market Challenges
11.4 Glycomics & Glycobiology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
